JP2023512526A5 - - Google Patents

Info

Publication number
JP2023512526A5
JP2023512526A5 JP2022546448A JP2022546448A JP2023512526A5 JP 2023512526 A5 JP2023512526 A5 JP 2023512526A5 JP 2022546448 A JP2022546448 A JP 2022546448A JP 2022546448 A JP2022546448 A JP 2022546448A JP 2023512526 A5 JP2023512526 A5 JP 2023512526A5
Authority
JP
Japan
Prior art keywords
nucleic acid
composition according
seq
acid sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022546448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512526A (ja
JP7855515B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/015126 external-priority patent/WO2021154752A1/en
Publication of JP2023512526A publication Critical patent/JP2023512526A/ja
Publication of JP2023512526A5 publication Critical patent/JP2023512526A5/ja
Application granted granted Critical
Publication of JP7855515B2 publication Critical patent/JP7855515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546448A 2020-01-28 2021-01-26 Ｂ型肝炎およびｄ型肝炎を治療および予防するための組成物および方法 Active JP7855515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062966970P 2020-01-28 2020-01-28
US62/966,970 2020-01-28
PCT/US2021/015126 WO2021154752A1 (en) 2020-01-28 2021-01-26 Compositions and methods for treating and preventing hepatitis b and d

Publications (3)

Publication Number Publication Date
JP2023512526A JP2023512526A (ja) 2023-03-27
JP2023512526A5 true JP2023512526A5 (https=) 2024-01-18
JP7855515B2 JP7855515B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
US11229694B2 (en) Vaccine against RSV
CN113817029B (zh) 一种新型冠状病毒s-rbd三聚体蛋白疫苗、其制备方法和应用
CA2299677A1 (en) Preparation and use of recombinant influenza a virus m2 constructs and vaccines
JP2004502460A5 (https=)
JP2023522154A5 (https=)
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CA3079486A1 (en) Mutant of hemagglutinin protein of h3n2 subtype influenza virus and use thereof
CN108456686B (zh) 一种用于展示目的多肽的多肽载体及其用途
JP2023512526A5 (https=)
JP2024539609A5 (https=)
CN119954972A (zh) 包含NHBA和fHbp的融合蛋白、包含其的免疫制剂及其制备方法和用途
CN105497884A (zh) 外膜蛋白Omp22作为鲍曼不动杆菌疫苗靶点的应用
EP3046936A1 (en) Treatment of hepatitis d virus infections by redirection of t cells
KR101635672B1 (ko) Ａ형 간염 바이러스 백신 소재 단백질 3ｄ2 및 백신 조성물
JP3532510B2 (ja) 組換え豚丹毒菌防御抗原の回収精製法
CA2996497C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2021522864A5 (https=)
CN119978138A (zh) 包含冠状病毒的保守重组蛋白片段的疫苗组合物及其应用
JPWO2023171719A5 (https=)
JP2023182231A5 (https=)
AU2009230776B2 (en) Neisseria meningitidis antigens and compositions
HK40051815A (en) Vaccine against rsv comprising modified f polypeptide
WO2026071026A1 (ja) インフルエンザウイルスワクチン
AU2014274586B2 (en) Nucleic acids and proteins from streptococcus groups A & B
JP2024526293A5 (https=)